MDisrupt – Medical Diligence Company
Ruby Gadelrab, CEO and Co-founder of MDisrupt, the first-of-its-kind medical diligence company, discusses how they are helping health-tech startups demonstrate viability and bring health products to market faster and more responsibly. The company is also launching an on-demand health industry expert platform to connect a wide range of highly specialized medical and scientific professionals with emerging health tech companies that will most benefit from their expertise.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Healthcare?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Ruby Gadelrab is a seasoned commercial health executive who has over 20 years of experience in biotech, healthcare and healthtech industries. Ruby is the CEO and Co-founder of MDisrupt the world’s first medical diligence company. In addition Ruby is the CEO of Ruby Consulting Group which was founded to help companies in the genetics, healthcare and healthtech spaces with their commercialization strategies. In the past two years, she has consulted for some of the leading companies in the genomics and health-tech space, including Genome Medical, Color Genomics, Drawbridge Health and Genomics PLC. She is also an advisor and mentor to many others. Ruby specializes in Genomics and her last role was to serve on the executive team of 23andMe as the Vice President of Commercial Marketing. Prior to this, she worked for a number of high profile companies including Life Technologies, Affymetrix and Invitae. Ruby has a strong background in successfully developing B2B and B2C commercial strategies. She has a proven track record in high impact marketing, branding, channel and commercialization initiatives.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
